Aduhelm Could Breathe New Life Into Alzheimer’s Diagnostics Such As Amyvid As CMS pursues a National Coverage Determination for monoclonal antibodies targeting amyloid beta plaque, such as Aduhelm, this could result in a boon for brain scans - such as Amyvid, an amyloid PET imaging scan - that evaluate amyloid beta neuritic plaque density.